#digitalneuroscience #brainhealth #Actinogen #ActinogenMedical #neuropsychiatricdiseases #CambridgeCognition #emestedastat #Xanamem #CANTABAttention #Alzheimersresearch #AlzheimersDisease #XanaMIAclinicaltrail #dementia #plasmabiomarker #biomarker #pTau181
pharmatimes.com/news/actinog...
pharmatimes.com/news/actinog...
Actinogen boosts trial with Cambridge Cognition's digital suite - PharmaTimes
Partnership aims to advance Alzheimer's research with innovative tools
pharmatimes.com
January 20, 2025 at 9:51 AM